Drug intelligence / Profile preview

Qutenza (capsaicin)

Development stage
Approved
Lead developer
Averitas Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

Qutenza is a high-concentration (8%) topical patch of capsaicin, a selective agonist of the transient receptor potential vanilloid 1 (TRPV1) channel. Developed to treat peripheral neuropathic pain, it works by delivering a high dose of capsaicin directly to the skin, which initially overstimulates and subsequently desensitizes or defunctionalizes TRPV1-expressing nociceptive nerve fibers. This process leads to a long-lasting reduction in pain sensitivity in the treated area. It is primarily indicated for postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet. Unlike low-concentration over-the-counter capsaicin creams, Qutenza is a physician-administered treatment that provides relief for up to three months following a single application.

Brand names
Qutenza
Other names
capsaicin 8% patchcapsaicin topical system
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Qutenza (capsaicin).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qutenza (capsaicin).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call